focr.ir
Provided by Alexa ranking, focr.ir has ranked N/A in N/A and 2558045th on the world. It is hoted in N/A with IP address 185.211.59.7. The home page has 0 external link.
Top keyword related from Search Engine of focr.ir
Traffic Ranks of focr.ir
Owner: |
N/A |
RANK: |
2558045 |
Country code: |
N/A |
Country name: |
N/A |
Rank on country: |
N/A |
Host: |
N/A |
Ip: |
185.211.59.7 |
Ref link: |
|
Extension: |
ir |
-
1. Homepage - Friends of Cancer Research
Link: https://friendsofcancerresearch.org/
Description: WebProgressforPatients.org brings together patients and their advocates as we work to incorporate the patient voice into research and drug development.
-
2. Breakthrough Therapies - Friends of Cancer Research
Link: https://friendsofcancerresearch.org/breakthrough-therapies/
Description: WebBreakthrough Therapies - Friends of Cancer Research. The Breakthrough therapies chart is a list of all publicly announced breakthrough therapy designations since the program’s inception in 2012.
-
3. About Friends - Friends of Cancer Research
Link: https://friendsofcancerresearch.org/about-friends/
Description: WebFounded in 1996, by Ellen Sigal and Marlene Malek to commemorate the 25th anniversary of the National Cancer Act, Friends is committed to creating and implementing policies ensuring patients receive the best treatments in the fastest and safest way possible.
-
4. FOCR Launches Digital Pathology Harmonization Project
Link: https://www.discoveriesinhealthpolicy.com/2024/02/focr-launches-digital-pathology-project.html
Description: WebWashington, DC – February 1st, 2024 - Friends of Cancer Research (Friends) is excited to announce the launch of a new research partnership, Digital and Computational Pathology Tool Harmonization (Digital PATH) Project. This project will identify factors that may contribute to variability in biomarker assessment across computational pathology ...
-
5. Reflections on 10 years of the FDA’s breakthrough therapy
Link: https://www.nature.com/articles/d41573-022-00053-x
Description: WebMar 15, 2022 · By. Asher Mullard. Credit: Friends of Cancer Research. Ellen Sigal, the founder of the patient advocacy group Friends of Cancer Research (FOCR), is a self-described accidental tourist in the...
-
6. FOCR Meeting Highlights Modernization of Expedited FDA Drug
Link: https://journals.lww.com/oncology-times/fulltext/2020/12200/focr_meeting_highlights_modernization_of_expedited.16.aspx
Description: WebDec 20, 2020 · The Friends of Cancer Research (FOCR) held the first of a two-part virtual annual meeting, which focused on ways of updating expedited drug approvals at the FDA. Modernization of expedited approval pathways is especially important for oncology, because since 2012 the vast majority of oncology drugs have used an expedited FDA approval …
-
7. What does FOCR stand for? - Abbreviations.com
Link: https://www.abbreviations.com/FOCR
Description: WebLooking for the definition of FOCR? Find out what is the full meaning of FOCR on Abbreviations.com! 'Friends of Cancer Research' is one option -- get in to view more @ The Web's largest and most authoritative acronyms and abbreviations resource.
-
8. FOCR offers path for validating ctDNA as an early endpoint for …
Link: https://www.raps.org/news-and-articles/news-articles/2022/7/focr-offers-path-for-validating-ctdna-as-an-early
Description: WebRegulatory News | 25 July 2022 | Mary Ellen Schneider. Friends of Cancer Research (FOCR) has issued an evidentiary roadmap for validating circulatory tumor DNA (ctDNA) as an early endpoint for accelerated drug approval in solid tumors, spelling out a strategy for generating the data needed to support the use of ctDNA levels as a drug ...
-
9. FOCR Annual Meeting Focuses on New Drugs & Diagnostics
Link: https://journals.lww.com/oncology-times/fulltext/2020/01050/focr_annual_meeting_focuses_on_new_drugs__.8.aspx
Description: WebJan 5, 2020 · diagnostics. In its continuing efforts to help ensure that patients receive the best treatments in the safest and fastest way possible, the Friends of Cancer Research (FOCR) announced a new pilot project called ctMoniTR at its annual meeting, held in Washington, D.C.
-
10. Rethinking the Accelerated Approval Pathway at the FDA
Link: https://journals.lww.com/oncology-times/Fulltext/2020/12200/Rethinking_the_Accelerated_Approval_Pathway_at_the.21.aspx
Description: WebOne assessment cited in a new white paper from the Friends of Cancer Research (FOCR) found that therapies approved through this accelerated pathway became available a median of 3.4 years earlier than would be achievable through the traditional FDA approval pathway.